| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.35 | 3e-27 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.24 | 9e-13 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.34 | 1e-12 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.25 | 2e-11 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-09 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | 0.96 | 8e-09 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-08 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-08 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.18 | 6e-08 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.17 | 7e-08 |